A Trial to Evaluate Pharmacokinetics, Immunogenicity, Safety, and Tolerability of LEO 138559 in Healthy Japanese Subjects

Clinical trial NCT05099133 · COMPLETED

Trial details

NCT number: NCT05099133
Sponsor: LEO Pharma
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2021-11-03
Primary completion: 2022-06-28
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.